AIDX

$0.23-0.04%visit website

20/20 Biolabs, Inc.

Market Cap

$3M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

—

Insufficient price history

P/E (TTM)

N/M

TTM to Dec 2025 · negative earnings

P/S (TTM)

1.5

TTM to Dec 2025 · revenue

P/B

N/M

TTM to Dec 2025 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Mar 2025 Mar 31, 2025	Jun 2025 Jun 30, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	554	535	353	731
Cost of revenue	388	372	290	426
Gross profit	166	163	63	305
Research & development	137	194	153	258
Selling, general & administrative	801	815	1,353	1,291
Total operating expenses	938	1,009	1,506	1,549
Operating income	(772)	(846)	(1,443)	(1,244)
Interest expense	1	1	267	272
Net income	(765)	(841)	(2,175)	(1,506)
EPS (basic) ($)	(0.16)	(0.17)	(0.28)	(0.26)	—
EPS (diluted) ($)	(0.16)	(0.17)	(0.28)	(0.26)	—
Weighted avg. shares (basic)	4,823	4,823	7,657	10,791
Weighted avg. shares (diluted)	4,823	4,823	7,657	10,791

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Corporate Events (8-K)

12 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Sep 18, 2026 accepted 8:05 PM ET	5.07Shareholder vote	Document SEC ↗
Sep 10, 2026 accepted 8:10 PM ET	3.01Delisting notice	Document SEC ↗
Sep 2, 2026 accepted 8:32 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 19, 2026 accepted 1:19 PM ET	5.07Shareholder vote	Document SEC ↗
Aug 17, 2026 accepted 8:05 PM ET	2.02Earnings release	Document SEC ↗
Aug 5, 2026 accepted 4:00 PM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 22, 2026 accepted 8:45 PM ET	1.01Material agreement3.01Delisting notice	Document SEC ↗
Jul 1, 2026 accepted 7:28 PM ET	7.01Reg FD disclosure	Document SEC ↗
May 26, 2026 accepted 8:28 PM ET	3.03Holder rights modified5.03Bylaws / fiscal year	Document SEC ↗
May 20, 2026 accepted 8:10 PM ET	2.02Earnings release	Document SEC ↗